Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Actiphage test crowned Royal Dairy Innovation Award winner

PBD Biotech’s novel Actiphage® testing technology was crowned winner of the Royal Dairy Innovation Award at Dairy-Tech 2019
  • February 6, 2019
  • Award

PBD Biotech’s novel Actiphage® testing technology was crowned winner of the Royal Dairy Innovation Award at Dairy-Tech 2019 (6 February 2019). The Royal Dairy Innovation trophy and certificate are awarded for research and development in the field of dairy farming. With the award going to the most practical, relevant product, which is likely to be the most significant innovation for the future of dairying.

Actiphage is an innovative new test for the rapid detection of bovine TB, Johne’s disease and other mycobacterial infections. It has the potential to expedite food safety checks on milk and dairy products; revolutionise livestock disease management; and ease the burden on farmers, the industry and wider public.

Receiving the award from HRH The Princess Royal, CEO of PBD Biotech Dr Berwyn Clarke said: “The dairy industry is known as an early-adopter of innovation, so we’re delighted Actiphage has been recognised amongst such a strong field of emerging tech and forward-thinking services.

Every year, Johne’s disease costs UK farmers and industry at least £13million and an increasing number of retailers are removing suppliers from their milk pool if they are not engaged in Johne’s disease testing. Again in the UK alone, bovine TB results in almost 44,000 cattle slaughtered annually and an estimated cost to the taxpayer of £100million.
PBD Biotech’s Actiphage fits into current animal health testing practices and is the only diagnostic able to detect live mycobacteria – differentiating between infection and vaccination – that delivers results within 6 hours.
Originally developed as a tool for diagnosis of human TB, Actiphage has been optimised and developed to provide enhanced sensitivity and specificity for use in blood or milk samples.

“Globally there is growing concern regarding the presence of live mycobacteria in milk that may have human health implications. This prestigious award is recognition of the opportunity this technology provides to ensure dairy products are free from these organisms as part of routine dairy quality control,” added Dr Clarke.

“We are seeing significant interest from dairy organisations throughout the world in Actiphage, and this award will significantly aid in transferring our technology into those global markets.”

Share:

Related posts

Loading...
British Farming Awards 2021 shortlist

PBD Biotech shortlisted for British Farming Awards

August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a shortlisting in the Agri-Tech Innovator of the Year of the British Farming Awards.
British Farming Awards 2021 shortlist

PBD Biotech shortlisted for British Farming Awards

August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a...
Mark Hammond (web)

Actiphage wins Vet Record Innovation Award 2021

February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood or milk, has been awarded the Innovation Award 2021 (15th February 2021) by Veterinary Record, the official journal of the...
Mark Hammond (web)

Actiphage wins Vet Record Innovation Award 2021

February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021. The award is for an innovation that has brought about – or has the potential to bring about – a...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021....
PBD Biotech - Cream Awards Winners

Rapid Actiphage test for bovine TB and Johne’s wins Cream Award for Innovation

February 6, 2020
The dairy industry has presented The Cream Award for Innovation to PBD Biotech for its rapid Actiphage® test, which can detect both bovine TB and Johne’s disease infections from a single sample of blood or milk.
PBD Biotech - Cream Awards Winners

Rapid Actiphage test for bovine TB and Johne’s wins Cream Award for Innovation

February 6, 2020
The dairy industry has presented The Cream Award for Innovation to PBD Biotech for its rapid Actiphage® test, which can...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More